Clinical Trials Directory

Trials / Completed

CompletedNCT03151278

Zero Fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for Right Atrial Arrhythmias

Multi-center, Randomized, Controlled Trial to Compare Feasibility, Safety and Efficacy of Zero-Fluoroscopic Navigation With Conventional Fluoroscopic Navigation for the Ablation of Right Atrial Arrhythmias

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
212 (actual)
Sponsor
Tongji Hospital · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This study is intended to compare the feasibility, safety and efficacy of a zero-fluoroscopic approach with conventional fluoroscopic approach as performing catheter ablation of right atrial arrhythmias.

Detailed description

Catheter ablation is a well-established treatment to treat patients with a wide range of heart rhythm disturbances. Fluoroscopy is the imaging modality routinely used for cardiac device implantation and electrophysiological procedures. Due to the rising concern regarding the harmful effects of radiation exposure to both the patients and operation staffs, novel three-dimensional mapping systems such as Ensite NavX have been developed and implemented in electrophysiological procedure for the navigation of catheters inside the heart chambers. Ensite NavX is a promising system to guide catheters inside the cardiac chambers and vessels without the use of fluoroscopy. This study is intended to compare the feasibility, safety and efficacy of a zero-fluoroscopic approach with conventional fluoroscopic approach as performing catheter ablation of right atrial arrhythmias.

Conditions

Interventions

TypeNameDescription
PROCEDUREZero-fluoroscopy ablationCatheter ablation will be performed under the guidance of one kind of three-dimensional navigation system and without fluoroscopic guidance.
PROCEDUREConventional fluoroscopy ablationCatheter ablation will be performed using fluoroscopy plus one kind of three-dimensional navigation system.

Timeline

Start date
2011-01-01
Primary completion
2017-12-01
Completion
2018-12-01
First posted
2017-05-12
Last updated
2023-11-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03151278. Inclusion in this directory is not an endorsement.